Home > Listed Companies Info. > Main Board Companies

:::

:::Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile

General Stock Board Listed Company Profile

Code:

Industry:

Local/Foreign Company:

4743 ONENESS BIOTECH

中文

Company Profile

Chairman

CEO

Spokesperson

Tel

Address

Date of Listing (Regular)

Shan-Ney Huang

Shu-ling Cheng

02-27031098

35F., No. 66, Sec. 1, Zhongxiao W. Rd., Zhongzheng Dist., Taipei City 100Taipei, Taiwan

2011/09/23

Industry

Main Business

Biotechnology and Medical Care

Oneness Biotech is dedicated to develop first-in-class and best-in-class new drugs to fulfil unmet medical need in chronic dermatologic and immunological disorders. With the established proprietary platform, Oneness can develop antibodies with high affinity and specificity in an efficient manner and is with full capacity to propel pipeline development from preclinical to clinical stages. Its lead drugs for diabetic foot ulcers has been approved by Taiwan FDA in March 2021 and being launched into the global market. Oneness further drives the pipeline into different clinical stages where 1 botanical new drug is under phase 3 and Fast Track designation in the U.S., 2 antibodies under phase 2 studies and 1 small molecule under phase 1 study. By upholding its business principle to create and share "health, happiness, and love" with commitment in "developing new drugs and caring for life", Oneness continuously takes initiatives to turn innovation into medicines for the benefits of patients.

Shr. Vol.	Highest	Lowest	Closed	Change	Transaction	TurnOver(%)	long margin balance (1,000shr.)	Short margin balance (1,000shr.)
Market Information ( 2024/04/24 )
1492.343	157.00	153.00	153.50	-1.50	1985	.00	13,886	159
Trading method	Fun purchase price or securities pneeded on T day	Announcement of Irregularity (2024/04/24)	TPEx measures adopted (2024/04/24)		With warrants	Can be shorted or margined?	Detail
Normal	N	N	N		N	Y	Today	History

Financial Reports
Cash Flows	Items
	Items	Amount (NT$ thousand)
	Cash flows from operating activities
	Cash flows from investing activities
	Cash flows from financing activities
Balance Sheets	Current assets
	Non-current assets
	Total assets
	Current liabilities
	Non-current liabilities
	Total liabilities
	Share capital
	Capital surplus
	Retained earnings
	Other equity interest
	Treasury shares
	Total equity attributable to owners of parent
	Non-controlling interests
	Total equity
	Book Value per share(NT$)
Comprehensive Income	Operating revenue
	Operating costs
	Gross profit from operations
	Operating expenses
	Net other income (expenses)
	Net operating income
	Non-operating income and expenses
	Profit before tax
	Tax expense
	Profit from continuing operations
	Profit from discontinued operations
	Profit
	Other comprehensive income
	Comprehensive income
	Basic earnings per share

Auditor's report on latest financial statements： auditor's report：

More detail:MOPS。

Foreign issuers’ information is disclosed in consolidated statements.

TOP

TPEx

Listed Companies

General Stock Board Listed Company Profile